Related Experiment Videos
Clinical characteristics of Chlamydia pneumoniae pneumonia in 145 children: a single-centre retrospective study
Yongkang Wang1, Tianyu Huang1, Weikang Gao1
1Department No. 1 of Respiratory Medicine, Xi'an Children's Hospital/National Regional Center for Children's Health, Xi'an, China.
Insights
Chlamydia pneumoniae pneumonia in children often presents with cough and minimal fever in older children. Recognizing these clinical features aids in prompt diagnosis and treatment of childhood C. pneumoniae pneumonia.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Chlamydia pneumoniae (CP) is a significant cause of community-acquired pneumonia in children.
- Understanding the specific clinical profile of CP pneumonia is crucial for accurate diagnosis and management.
Purpose of the Study:
- To summarize the clinical features of Chlamydia pneumoniae pneumonia in pediatric patients.
- To identify key indicators for early diagnosis and targeted therapy.
Main Methods:
- A retrospective cross-sectional study was conducted.
- Clinical data from 145 children diagnosed with CP pneumonia were analyzed.
- Data included demographics, clinical symptoms, laboratory results, imaging, and treatment.
Main Results:
- Cough was the predominant symptom (99.3%), often without significant fever (44.8%).
- Unilateral lung involvement was common (109 cases).
- Azithromycin and doxycycline were the primary treatments used.
Conclusions:
- Older children with cough, minimal fever, lobar consolidation, and normal inflammatory markers may have CP pneumonia.
- Early identification of these characteristic signs improves diagnostic accuracy and treatment timeliness for childhood CP pneumonia.
Objective:
This study aimed to summarize the clinical features of Chlamydia pneumoniae pneumonia in children.
Methods:
We conducted a single-centre retrospective cross-sectional study by retrospectively collecting clinical data from 145 children diagnosed with Chlamydia pneumoniae pneumonia at Xi'an Children's Hospital, between January 1 and July 30, 2025. Demographic information, clinical manifestations, laboratory test results, pulmonary imaging findings, and treatment details were analyzed.
Results:
Among the 145 children, 89 were male and 56 were female. The median age at onset was 11 years (IQR: 8.33-12.42), and the median disease duration was 14 days (IQR: 12-18). Cough was present in 144 cases (99.3%), with wet cough being predominant (141 cases, 97.2%). Fever was observed in 65 cases (44.8%), primarily low to moderate grade, with a median peak temperature of 38.5°C (IQR: 38.0-39.0). Nasal congestion was noted in 43 cases (29.7%), chest pain in 11 (7.6%), and both rash and hemoptysis in 5 cases each (3.4%). Laboratory results showed a median white blood cell count of 8.09 × 109/L (IQR: 6.43-9.58), a mean neutrophil of 4.65 × 109/L (IQR: 3.44-6.14), a mean lymphocyte of 2.41 × 109/L (IQR: 1.88-2.91), a median neutrophil-lymphocyte ratio of 1.95 (IQR: 1.32-2.99), and a median CRP level of 4.39 mg/L (IQR: 0.86-11.77). Unilateral lung involvement was observed in 109 cases, while bilateral involvement was seen in 36. Bronchoscopy was performed on 36 patients. Regarding treatment, 93 children received azithromycin, and 65 received doxycycline for anti-infective therapy.
Conclusion:
Older children who mainly suffer from cough and expectoration, with no fever or low-grade fever, pleural-based lobar consolidation on chest radiography, and normal leukocyte counts and inflammatory biomarkers, are highly likely to be diagnosed with CP pneumonia. Early recognition of these characteristic manifestations can facilitate timely diagnosis and targeted antimicrobial therapy for childhood CPP.
Related Concept Videos
Atypical Pneumonia
Bacterial Phylum Chlamydiae
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology